🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New Features Roundup: • Menu Bar (macOS) & System Tray (Windows & Linux) Access • Quick Search with Command/Ctrl+K • Soundboard & Emoji are now available in Private Offices and Team Rooms

Thanks Brian Sozzi for having me on this morning. Enjoyed talking about Bausch + Lomb and all things health care!

"We should have real pricing transparency on healthcare services in the US," Bausch + Lomb CEO Brent Saunders says. "We should understand why we pay what we pay, where can you get it, perhaps at a lower cost, who's getting paid, where is the money going."

AI hardware engineers are here and hard at work. Thanks for the shoutout Bausch + Lomb and Brent Saunders Saunders on B&L’s earnings call and congrats to the entire team at B&L on a stellar year. At Arena , we’re honored to be your partner, and happy to hear that our Atlas

👏👏👏 delian

***@roam February Investor Update*** We had a strong February. +7.0% ARR Month over Month +6.7 Logo Count: (MoM) +106% Retention (Monthly) +305 inbound trials/demos Onward!

🚨 NEW INVESTMENT 🇺🇸 Sequoia led a $190M Series C in Peregrine. Peregrine makes software that helps mission-critical organizations (public safety, law enforcement, government, enterprises) integrate and analyze their data, and build operational applications on top of it.

FDA has approved the #neffy 1 mg epinephrine nasal spray for younger kids 4 and up, weighing 30-66 lbs. Allergic Living gets details on the rollout, administering to kids & data on the device. Plus, latest on insurance coverage for both neffy strengths. ARS Pharmaceuticals #foodallergy

After four and a half years of building, I’m beyond excited to announce today family planning via genetic matching on Nucleus Genomics. Imagine knowing nearly every possible genetic outcome for you and your partner’s future children, starting with your future children’s risk of

It's a crazy, mad world for your Medicare patients and their drug costs, and here's why: healio.com/news/ophthalmo… Look for my next post on so-called "opt out" programs. Preeya K. Gupta Leslie E. O’Dell OD FAAO Laura M Periman MD Aziz Mottiwala Brent Saunders Inder Paul Singh Nathan Radcliffe

Today, I'm excited to announce Arena's $30M Series B and to introduce Atlas – an AI hardware engineer that is used by many of the world's most respected and ambitious hardware companies – in semiconductors, aerospace, automotive, medical devices, and defense. We’re hiring

Thrilled to support and advise my good friend Anthony Pompliano 🌪 on his IPO today. Thanks Squawk Box and Andrew Ross Sorkin for having us on CNBC today.

Funding secured. Today I am launching a $250 million acquisition vehicle with Brent Saunders in hopes of bringing a profitable company into the public markets. $PCAPU

Nearly two out of three American adults surveyed report having eye or vision problems. However, most people do not prioritize eye exams that could safeguard their sight. Book a screening at a Walmart Vision Center and view our product line: bit.ly/4ilFwga

For those unable to attend today's live On-It launch, here's the Magicast. You'll never see a product launch like this. ro.am/share/m4bbbh7x…

😂

Proud of my ⁦Bausch + Lomb⁩ team for delivering a solid Q2 through continued growth that speaks to the breadth and depth of our portfolio and is driven by a mix of hero products and a steady stream of new introductions around the world. finance.yahoo.com/news/bausch-lo…

🚨July Roam Investor Update🚨 Our greatest month ever

🚀